Neoadjuvant PD-1 Blockade in Resectable Lung Cancer; Nivolumab and Ipilimumab in Advanced Melanoma; Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma; Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy; Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma; Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma; Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma; Rapid Eradication of a Bulky Melanoma Mass with One Dose of Immunotherapy; Genetic Basis for Clinical Response to CTLA-4 Blockade; Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma; Nivolumab plus Ipilimumab in Advanced Melanoma; Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma; Hepatotoxicity with Combination of Vemurafenib and IpilimumabNew England Journal of Medicine · 2018

Granulomatous dermatitis associated with ipilimumab therapy (Ipilimumab associated granulomatous dermatitis)Kubicki, Shelby L; Welborn, Macartney E; Garg, Naveen; Aung, Phyu P; Patel, Anisha B · Journal of Cutaneous Pathology · 2018

Nivolumab und Ipilimumab beim Nierenzellkarzinom; Nivolumab and ipilimumab in renal cell carcinoma;Alakus, Hakan; Zander, Thomas; Bruns, Christiane · Der Onkologe · 2018

Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic MelanomaHodi, F. Stephen; Lee, Sandra; McDermott, David F.; Rao, Uma N.; Butterfield, Lisa H.; Tarhini, Ahmad A.; Leming, Philip; Puzanov, Igor; Shin, Donghoon; Kirkwood, John M. · JAMA · 2014

Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanomaKirchberger, Michael C.; Hauschild, Axel; Schuler, Gerold; Heinzerling, Lucie · European Journal of Cancer · 2016

Nivolumab and Ipilimumab versus Ipilimumab in Untreated MelanomaPostow, Michael A.; Chesney, Jason; Pavlick, Anna C.; Robert, Caroline; Grossmann, Kenneth; McDermott, David; Linette, Gerald P.; Meyer, Nicolas; Giguere, Jeffrey K.; Agarwala, Sanjiv S.; Shaheen, Montaser; Ernstoff, Marc S.; Minor, David; Salama, April K.; Taylor, Matthew; Ott, Patrick A.; Rollin, Linda M.; Horak, Christine; Gagnier, Paul; Wolchok, Jedd D.; Hodi, F. Stephen · New England Journal of Medicine · 2015

79 Ipilimumab-Related Colitis in Patients with Advanced Melanoma Receiving Ipilimumab Therapy: Histopathologic and Serologic CharacterizationHanlin L. Wang; Zenta Tsuchihashi; Stephan R. Targan; Susan M. Parker; Jonathan Siegel; David Berman · 2009

Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanomaPotluri, Ravi; Ranjan, Sandip; Bhandari, Hitesh; Johnson, Helen; Moshyk, Andriy; Kotapati, Srividya · Experimental Hematology & Oncology · 2019

Mefenamic acidRodrigues, Manuel E.; Marques, Glauber Tadaiesky · Reactions Weekly · 2013

Sildenafil/tadalafilRodrigues, Manuel E.; Marques, Glauber Tadaiesky · Reactions Weekly · 2013

DocetaxelRodrigues, Manuel E.; Marques, Glauber Tadaiesky · Reactions Weekly · 2013

AntiretroviralsRodrigues, Manuel E.; Marques, Glauber Tadaiesky · Reactions Weekly · 2013

Iodine/thyroidRodrigues, Manuel E.; Marques, Glauber Tadaiesky · Reactions Weekly · 2013

Thermodynamics of a class of non-asymptotically flat black holes in Einstein–Maxwell–Dilaton theoryRodrigues, Manuel E.; Marques, Glauber Tadaiesky · General Relativity and Gravitation · 2013

Biperiden/trihexyphenidylReactions Weekly · 1995

NitrendipineReactions Weekly · 2003

ScopolamineReactions Weekly · 2007

ScopolamineReactions Weekly · 2012

ScopolamineReactions Weekly · 2009

Centella asiaticaReactions Weekly · 2011

Daunorubicin/mitoxantroneReactions Weekly · 2007

AnthracyclinesReactions Weekly · 1991